Clinical Trial Update: Xenazine in Late Dyskinetic Syndrome With Neuroleptics [Phase 3]

View source ↗

Summary

Phase 3 trial update on Xenazine (tetrabenazine) for tardive dyskinesia in patients treated with neuroleptics; the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tardive Dyskinesia

Drugs mentioned

• Xenazine (tetrabenazine)

Snippet

Sponsor: Centre Hospitalier Universitaire, Amiens | Conditions: Tardive Dyskinesia | Phase 3 | Status: COMPLETED